Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-23

Clinical Trial Update: Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

View source ↗

Summary

This clinical trial update investigates the prognostic value of minimal residual disease in acute myeloid leukemia and notes the study as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Acute Myeloid Leukemia, Minimal Residual Disease | Status: COMPLETED